Literature DB >> 14570045

New tools for functional mammalian cancer genetics.

Thijn R Brummelkamp1, René Bernards.   

Abstract

Knowledge of the function of individual genes that encode components of cell-signalling pathways is crucial to our understanding of normal growth control and its deregulation in cancer, but we have functional information for only 15% of human genes at present. Several new technologies have recently become available to identify gene function in mammalian cells using high-throughput genetic screens. These new tools will make it possible to identify new and innovative classes of anticancer drugs, including those that show synthetic lethal interactions with cancer-specific mutations.

Entities:  

Mesh:

Year:  2003        PMID: 14570045     DOI: 10.1038/nrc1191

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  24 in total

Review 1.  Optimizing RNA interference for application in mammalian cells.

Authors:  René H Medema
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

2.  Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3.

Authors:  Amy Baldwin; Dorre A Grueneberg; Karin Hellner; Jacqueline Sawyer; Miranda Grace; Wenliang Li; Ed Harlow; Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

3.  Large-scale cDNA transfection screening for genes related to cancer development and progression.

Authors:  Dafang Wan; Yi Gong; Wenxin Qin; Pingping Zhang; Jinjun Li; Lin Wei; Xiaomei Zhou; Hongnian Li; Xiaokun Qiu; Fei Zhong; Liping He; Jian Yu; Genfu Yao; Huiqiu Jiang; Lianfang Qian; Ye Yu; Huiqun Shu; Xianlian Chen; Huili Xu; Minglei Guo; Zhimei Pan; Yan Chen; Chao Ge; Shengli Yang; Jianren Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

Review 4.  Making sense of cancer genomic data.

Authors:  Lynda Chin; William C Hahn; Gad Getz; Matthew Meyerson
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

5.  Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.

Authors:  Hua Gao; Goutam Chakraborty; Ai Ping Lee-Lim; Konstantinos J Mavrakis; Hans-Guido Wendel; Filippo G Giancotti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

6.  A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.

Authors:  Sabine Rottmann; Yan Wang; Marc Nasoff; Quinn L Deveraux; Kim C Quon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-06       Impact factor: 11.205

7.  Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

Authors:  P Storm; S Aits; M K Puthia; A Urbano; T Northen; S Powers; B Bowen; Y Chao; W Reindl; D Y Lee; N L Sullivan; J Zhang; M Trulsson; H Yang; J D Watson; C Svanborg
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

8.  Pooled RNAi Screens - Technical and Biological Aspects.

Authors:  M Boettcher; J D Hoheisel
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

9.  Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer.

Authors:  Sun Tian; Paul Roepman; Laura J Van't Veer; Rene Bernards; Femke de Snoo; Annuska M Glas
Journal:  Biomark Insights       Date:  2010-11-28

10.  Designer siRNAs to overcome the challenges from the RNAi pathway.

Authors:  Sumedha D Jayasena
Journal:  J RNAi Gene Silencing       Date:  2005-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.